Amarin should sell the brand to BP and retain the rights to the generic, and form a buying alliance with them for API.
This would help Amarin, the shareholders, and the BP.
Amarin could eliminate most of its overhead and just sell the generic IE at a MUCH higher profit than currently (because there would be virtually no overhead, and API would be cheaper).
BP could sell the brand, along with it's next iteration of drug (MND-2119, FDC, etc.).
He might have a dirty, kind of disheveled rabbit to pull out
Too funny
Did you note how so many of the perceived experts have evaporated from this board. Yes its been a great pump and dump plan over the years but alas there is very little left to pump - except of course GREENLAND !!!
NOtice how when I asked I think his name telhsu or something like that how HUngary was (Gabor) he disappeared ...lol
News 
Market Data 
Discover 
